By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Immune Targeting Systems (ITS) Ltd. 



London      United Kingdom
Phone: Fax:


SEARCH JOBS


Industry
Biotechnology






Company News
Immune Targeting Systems (ITS) Ltd. And WCCT Global Announce A New Influenza A H1N1 Virus To Support The Experimental Human Viral Challenge Model 8/18/2014 8:28:53 AM
Immune Targeting Systems (ITS) Ltd. Announces Positive Phase 2a Data in the at Risk Elderly Population With Flunisyn™, Its Pan-Strain Influenza a T-Cell Vaccine, and Two UK Biomedical Catalyst Grants for Chronic Hepatitis B and Oncology 4/17/2013 9:05:41 AM
Immune Targeting Systems (ITS) Ltd. Announces Positive Phase I Data for Flunisyn™, Its Pan-Strain Influenza A T-Cell Vaccine, and Changes to the Company's Senior Management Team 9/17/2012 9:15:45 AM
Immune Targeting Systems (ITS) Ltd. Announces First Patient Treated in Phase I Trial of Synthetic Universal Influenza Vaccine 9/15/2010 10:05:47 AM
Immune Targeting Systems (ITS) Ltd. Confirms Industry Heavyweight Ken Powell as New Chairman 11/16/2009 10:27:44 AM
Immune Targeting Systems (ITS) Ltd. Concludes a Series-A Funding Round of GBP 3.5M (EUR 5.2M) 7/16/2007 11:29:47 AM
//-->